Herbalife Ltd. (HLF) Reports Q2 2025 Results; Mizuho Lifts PT to $9

Herbalife Ltd. (NYSE:HLF) is included in our list of the 12 Cheap Value Stocks to Buy Now According to Seth Klarman.

Herbalife Ltd. (HLF) Reports Q2 2025 Results; Mizuho Lifts PT to $9

A healthcare facility with modern furniture and fume hoods.

On August 6, 2025, Herbalife Ltd. (NYSE:HLF) reported its results for Q2 2025. The company recorded net sales of $1.3 billion, which were down 1.7% year-over-year and flat on a constant currency basis. Meanwhile, its adjusted EBITDA of $173.6 million surpassed guidance. As such, HLF increased its full-year 2025 net sales and adjusted EBITDA outlook and lowered Capex forecasts.

Herbalife Ltd. (NYSE:HLF)’s management expressed increasing confidence following the July launches of MultiBurn, a multifunctional weight-loss supplement, and the beta release of the AI-assisted Pro2col digital platform. Over 7,000 distributors are already engaged ahead of a Q4 U.S. and Puerto Rico rollout. During the quarter, the company’s distributor growth remained strong, with Latin America leading the segment with a 16% YoY growth.

Ahead of the earnings release, Mizuho lifted its price target on Herbalife Ltd. (NYSE:HLF) from $8 to $9, maintaining a ‘Neutral’ rating. The company also maintained its financial health steady at the quarter-end, redeeming $50 million of its 7.875% Senior Notes due 2025, maintaining leverage at 3.0x.

Offering science-backed nutrition products and a global distributor-driven business model, Herbalife Ltd. (NYSE:HLF) operates as a leading health and wellness company. It is included in our list of cheap value stocks to buy.

READ NEXT: 13 Best Oil Refinery Stocks to Buy Right Now and 7 Best Potash Stocks to Buy According to Analysts.

Disclosure: None.